SUPRIYA LIFESCIENCE
Quarterly Results Analysis [Dec2023]
SUPRIYA LIFESCIENCE Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹140 Cr | ₹140 Cr | ₹132 Cr | ₹142 Cr | ₹105 Cr | ₹112 Cr | ₹101 Cr | ₹181 Cr |
Expenses | ₹99 Cr | ₹108 Cr | ₹88 Cr | ₹87 Cr | ₹91 Cr | ₹84 Cr | ₹70 Cr | ₹106 Cr |
Operating Income | ₹41 Cr | ₹32 Cr | ₹44 Cr | ₹55 Cr | ₹14 Cr | ₹29 Cr | ₹31 Cr | ₹75 Cr |
Other Income | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹4 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹40 Cr | ₹30 Cr | ₹43 Cr | ₹53 Cr | ₹13 Cr | ₹27 Cr | ₹30 Cr | ₹75 Cr |
Profit After Tax | ₹30 Cr | ₹24 Cr | ₹29 Cr | ₹38 Cr | ₹10 Cr | ₹17 Cr | ₹25 Cr | ₹46 Cr |
EPS | ₹3.70 | ₹2.97 | ₹3.54 | ₹4.75 | ₹1.18 | ₹2.10 | ₹3.14 | ₹5.74 |
Industry Peers & Returns | 1W | 1M | 1Y |
SUPRIYA LIFESCIENCE | 2.8% | -6.7% | 81.4% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
SUPRIYA LIFESCIENCE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -0.01 % |
Y-o-Y | 33.23 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹140 Cr | -0.01 | |
Sep2023 | ₹140 Cr | 6.12 | |
Jun2023 | ₹132 Cr | -7.20 | |
Mar2023 | ₹142 Cr | 35.31 | |
Dec2022 | ₹105 Cr | -6.27 | |
Sep2022 | ₹112 Cr | 10.67 | |
Jun2022 | ₹101 Cr | -44.09 | |
Mar2022 | ₹181 Cr | - |
SUPRIYA LIFESCIENCE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 30.67 % |
Y-o-Y | 195.42 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹41 Cr | 30.67 | |
Sep2023 | ₹32 Cr | -28.63 | |
Jun2023 | ₹44 Cr | -19.17 | |
Mar2023 | ₹55 Cr | 291.95 | |
Dec2022 | ₹14 Cr | -50.83 | |
Sep2022 | ₹29 Cr | -8.59 | |
Jun2022 | ₹31 Cr | -58.46 | |
Mar2022 | ₹75 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 30.71 % |
Y-o-Y | 121.71 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 29.62% | 30.71 | |
Sep2023 | 22.66% | -32.76 | |
Jun2023 | 33.7% | -12.90 | |
Mar2023 | 38.69% | 189.60 | |
Dec2022 | 13.36% | -47.53 | |
Sep2022 | 25.46% | -17.42 | |
Jun2022 | 30.83% | -25.71 | |
Mar2022 | 41.5% | - |
SUPRIYA LIFESCIENCE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 24.72 % |
Y-o-Y | 213.00 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹30 Cr | 24.72 | |
Sep2023 | ₹24 Cr | -16.23 | |
Jun2023 | ₹29 Cr | -25.42 | |
Mar2023 | ₹38 Cr | 301.69 | |
Dec2022 | ₹10 Cr | -43.56 | |
Sep2022 | ₹17 Cr | -33.22 | |
Jun2022 | ₹25 Cr | -45.36 | |
Mar2022 | ₹46 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 24.75 % |
Y-o-Y | 135.03 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 21.27 % | 24.75 | |
Sep2023 | 17.05 % | -21.06 | |
Jun2023 | 21.6 % | -19.61 | |
Mar2023 | 26.87 % | 196.91 | |
Dec2022 | 9.05 % | -39.79 | |
Sep2022 | 15.03 % | -39.66 | |
Jun2022 | 24.91 % | -2.28 | |
Mar2022 | 25.49 % | - |
SUPRIYA LIFESCIENCE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 24.58 % |
Y-o-Y | 213.56 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹3.7 | 24.58 | |
Sep2023 | ₹2.97 | -16.10 | |
Jun2023 | ₹3.54 | -25.47 | |
Mar2023 | ₹4.75 | 302.54 | |
Dec2022 | ₹1.18 | -43.81 | |
Sep2022 | ₹2.1 | -33.12 | |
Jun2022 | ₹3.14 | -45.30 | |
Mar2022 | ₹5.74 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD